T1	Participants 74 119	moderate to severe facial erythema of rosacea
T2	Participants 204 223	Erythema of rosacea
T3	Participants 577 601	In study A, 122 subjects
T4	Participants 687 751	In study B (4-week treatment and 4-week follow-up), 269 subjects
T5	Participants 1834 1872	moderate to severe erythema of rosacea
T6	Participants 495 527	treatment of erythema of rosacea
